{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:35:24Z","timestamp":1775277324842,"version":"3.50.1"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","award":["AAP-2014-009"],"award-info":[{"award-number":["AAP-2014-009"]}],"id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Sickle cell disease (SCD) induces chronic haemolytic anaemia and intermittent vaso-occlusion that results in tissue ischaemia causing acute, severe pain episodes that can lead to frequent hospitalizations. These consequences can have repercussions on family, social, school and\/or professional life. Here, we present some of the results of the PHEDRE study (Pharmacod\u00e9pendance Et DREpanocytose\u2014drug dependence and sickle-cell disease), which is the largest study of patients with SCD in France. This paper intends to describe characteristics of the French SCD population. We also aimed to assess the impact of the disease on the lives of patients using objective and subjective variables.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>The PHEDRE study was a national multicentric observational study. Adults, adolescents and children with a confirmed SCD diagnosis were included in the study by their referring doctor. Then, they were interviewed by phone about their socioeconomic status, about the impact of the disease on their lives and about their analgesic and psychoactive drug use.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The study population consisted of 872 patients (28% were minors). Seventy-two percent of adults were active, and all minors were in school. Many patients presented criteria of severe SCD. Seventy-five percent were homozygous SS, 15% were double heterozygotes SC and 8% were heterozygotes S\u03b2thal, 87% received specific treatment, 58% were hospitalized at least once for vaso-occlusive crisis in the past 12 months, and the number of analgesic drugs taken averaged 3.8. Seventy-five percent of patients reported academic or professional consequences related to their SCD, and 52% reported social consequences.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The impact of SCD on patients\u2019 lives can be significant, nevertheless their social integration seems to be maintained. We highlighted respect of recommendations regarding analgesic treatments and only a few patients used tobacco, alcohol or cannabis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Trial registration<\/jats:title>\n<jats:p>Clinical Trials, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02580565\" xlink:type=\"simple\">NCT02580565<\/jats:ext-link>; <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/<\/jats:ext-link> Registered 16 October 2015.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0248649","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T17:41:46Z","timestamp":1616089306000},"page":"e0248649","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Descriptive analysis of sickle cell patients living in France: The PHEDRE cross-sectional study"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7404-6325","authenticated-orcid":true,"given":"Marie","family":"Gerardin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgane","family":"Rousselet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Laure","family":"Couec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agathe","family":"Masseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryl\u00e8ne","family":"Guerlais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Authier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Deheul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Roussin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joelle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Djezzar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"French Addictovigilance Network (FAN)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Feuillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Jolliet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Victorri-Vigneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"issue":"1","key":"pone.0248649.ref001","first-page":"4","article-title":"Differences in the clinical and genotypic presentation of sickle cell disease around the world","volume":"15","author":"SL Saraf","year":"2014","journal-title":"Paediatr Respir Rev"},{"issue":"9757","key":"pone.0248649.ref002","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease.","volume":"376","author":"DC Rees","year":"2010","journal-title":"Lancet Lond Engl"},{"issue":"9861","key":"pone.0248649.ref003","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"FB Piel","year":"2013","journal-title":"Lancet Lond Engl"},{"issue":"3","key":"pone.0248649.ref004","doi-asserted-by":"crossref","first-page":"e012665","DOI":"10.1136\/bmjopen-2016-012665","article-title":"Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case\u2013control analysis.","volume":"7","author":"I Little","year":"2017","journal-title":"BMJ Open"},{"issue":"5 Suppl 1","key":"pone.0248649.ref005","first-page":"5S3","article-title":"[French guidelines for the management of adult sickle cell disease: 2015 update].","volume":"36","author":"A Habibi","year":"2015","journal-title":"Rev Med Interne."},{"issue":"6","key":"pone.0248649.ref006","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2141.2005.05500.x","article-title":"Psychological complications in sickle cell disease","volume":"129","author":"KA Anie","year":"2005","journal-title":"Br J Haematol"},{"key":"pone.0248649.ref007","unstructured":"D\u00e9pistage n\u00e9onatal de la dr\u00e9panocytose en France [Internet]. Haute Autorit\u00e9 de Sant\u00e9. [cited 2021 Feb 01]. Available from: https:\/\/www.has-sante.fr\/jcms\/c_1728538\/fr\/depistage-neonatal-de-la-drepanocytose-en-france."},{"issue":"1","key":"pone.0248649.ref008","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/AJP.0b013e318245764b","article-title":"The management of sickle cell pain in the emergency department: a priority for health systems.","volume":"29","author":"C Po\u2019","year":"2013","journal-title":"Clin J Pain"},{"issue":"3","key":"pone.0248649.ref009","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s11845-018-1949-0","article-title":"Parental awareness of newborn bloodspot screening in Ireland.","volume":"188","author":"P Fitzpatrick","year":"2019","journal-title":"Ir J Med Sci."},{"key":"pone.0248649.ref010","volume-title":"Sickle Cell Anemia. In: StatPearls","author":"A Mangla","year":"2020"},{"issue":"9","key":"pone.0248649.ref011","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16091638","article-title":"Sickle Cell Anaemia Prevalence Among Newborns in the Brazilian Amazon-Savanna Transition Region.","volume":"16","author":"RC Souza","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"pone.0248649.ref012","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13023-019-1099-0","article-title":"Current challenges in the management of patients with sickle cell disease\u2013A report of the Italian experience","volume":"14","author":"G Russo","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"pone.0248649.ref013","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.disamonth.2017.12.003","article-title":"Sickle cell disease; An overview of the disease and its systemic effects.","volume":"64","author":"S Alrayyes","year":"2018","journal-title":"Dis\u2014Mon DM"},{"key":"pone.0248649.ref014","unstructured":"Orphanet: \u00c0 propos des maladies rares [Internet]. [cited 2021 Feb 01. Available from: https:\/\/www.orpha.net\/consor\/cgi-bin\/Education_AboutRareDiseases.php?lng = FR."},{"key":"pone.0248649.ref015","unstructured":"Dr\u00e9panocytose [Internet]. Inserm\u2014La science pour la sant\u00e9. [cited 2021 Feb 01]. Available from: https:\/\/www.inserm.fr\/information-en-sante\/dossiers-information\/drepanocytose."},{"key":"pone.0248649.ref016","unstructured":"Prise en charge de la dr\u00e9panocytose chez l\u2019enfant et l\u2019adolescent [Internet]. Haute Autorit\u00e9 de Sant\u00e9. [cited 2021 Feb 01]. Available from: https:\/\/www.has-sante.fr\/jcms\/c_272479\/en\/prise-en-charge-de-la-drepanocytose-chez-l-enfant-et-l-adolescent."},{"key":"pone.0248649.ref017","unstructured":"ald_10_guide_drepano_adulte_web.pdf [Internet]. [cited 2021 Feb 01]. Available from: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2010-04\/ald_10_guide_drepano_adulte_web.pdf."},{"key":"pone.0248649.ref018","unstructured":"ALD n\u00b0 10\u2014Syndromes dr\u00e9panocytaires majeurs de l\u2019adulte [Internet]. Haute Autorit\u00e9 de Sant\u00e9. [cited 2021 Feb 01]. Available from: https:\/\/www.has-sante.fr\/jcms\/c_938884\/fr\/ald-n-10-syndromes-drepanocytaires-majeurs-de-l-adulte."},{"key":"pone.0248649.ref019","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijnurstu.2017.12.008","article-title":"Adolescents\u2019 experiences of living with sickle cell disease: An integrative narrative review of the literature.","volume":"80","author":"BA Poku","year":"2018","journal-title":"Int J Nurs Stud"},{"issue":"1","key":"pone.0248649.ref020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12955-019-1136-7","article-title":"Psychometric analysis of the adult sickle cell quality of life measurement information system (ACSQ-Me) in a UK population.","volume":"17","author":"O Cooper","year":"2019","journal-title":"Health Qual Life Outcomes."},{"key":"pone.0248649.ref021","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12888-015-0677-5","article-title":"PHEDRE trial protocol\u2014observational study of the prevalence of problematic use of Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) and analgesics in the French sickle-cell disease population.","volume":"15","author":"M G\u00e9rardin","year":"2015","journal-title":"BMC Psychiatry."},{"key":"pone.0248649.ref022","unstructured":"Au premier trimestre 2019 le taux de ch\u00f4mage baisse de 0,1 point\u2014Informations rapides\u2014127 | Insee [Internet]. [cited 2019 Jul 31]. Available from: https:\/\/www.insee.fr\/fr\/statistiques\/4136766."},{"key":"pone.0248649.ref023","unstructured":"M\u00e9nages selon la structure familiale en 2016 | Insee [Internet]. [cited 2019 Jul 31]. Available from: https:\/\/www.insee.fr\/fr\/statistiques\/2381514."},{"key":"pone.0248649.ref024","unstructured":"Le retard scolaire \u00e0 l\u2019entr\u00e9e en 6e: plus fr\u00e9quent dans les territoires les plus d\u00e9favoris\u00e9s\u2014Insee Premi\u00e8re\u20141512 [Internet]. [cited 2019 Jul 31]. Available from: https:\/\/www.insee.fr\/fr\/statistiques\/1281332."},{"issue":"3","key":"pone.0248649.ref025","first-page":"267","article-title":"Daily mood and stress predict pain, health care use, and work activity in African American adults with sickle-cell disease.","volume":"23","author":"KM Gil","year":"2004","journal-title":"Health Psychol Off J Div Health Psychol Am Psychol Assoc."},{"issue":"2","key":"pone.0248649.ref026","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1353\/hpu.2018.0060","article-title":"Social and Behavioral Factors in Sickle Cell Disease: Employment Predicts Decreased Health Care Utilization.","volume":"29","author":"H Williams","year":"2018","journal-title":"J Health Care Poor Underserved"},{"issue":"Part 3","key":"pone.0248649.ref027","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1348\/135910702760213724","article-title":"The psychosocial experience of people with sickle cell disease and its impact on quality of life: Qualitative findings from focus groups.","volume":"7","author":"VJ Thomas","year":"2002","journal-title":"Br J Health Psychol"},{"issue":"4","key":"pone.0248649.ref028","first-page":"491","article-title":"SOCIOECONOMIC AND NUTRITIONAL CHARACTERISTICS OF CHILDREN AND ADOLESCENTS WITH SICKLE CELL ANEMIA: A SYSTEMATIC REVIEW.","volume":"36","author":"AC da S de Jesus","year":"2018","journal-title":"Rev Paul Pediatr Orgao Of Soc Pediatr Sao Paulo"},{"issue":"5","key":"pone.0248649.ref029","first-page":"424","article-title":"The Daily Experiences of Adolescents in Lebanon With Sickle Cell Disease","volume":"29","author":"M Atoui","year":"2015","journal-title":"J Pediatr Health Care Off Publ Natl Assoc Pediatr Nurse Assoc Pract"},{"issue":"1","key":"pone.0248649.ref030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1043454214555193","article-title":"Perception of pain among pediatric patients with sickle cell pain crisis","volume":"32","author":"MB Fosdal","year":"2015","journal-title":"J Pediatr Oncol Nurs Off J Assoc Pediatr Oncol Nurses"},{"issue":"3","key":"pone.0248649.ref031","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4103\/0300-1652.160397","article-title":"Adolescents with sickle cell anaemia: Experience in a private tertiary hospital serving a tertiary institution.","volume":"56","author":"S John-Olabode","year":"2015","journal-title":"Niger Med J J Niger Med Assoc"},{"issue":"3","key":"pone.0248649.ref032","first-page":"113","article-title":"Depression, Anxiety, and Quality of Life In Children and Adolescents With Sickle Cell Disease.","volume":"42","author":"JK Graves","year":"2016","journal-title":"Pediatr Nurs"},{"issue":"2","key":"pone.0248649.ref033","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MPH.0000000000001067","article-title":"Sleep Problem Risk for Adolescents With Sickle Cell Disease: Sociodemographic, Physical, and Disease-related Correlates","volume":"40","author":"CR Valrie","year":"2018","journal-title":"J Pediatr Hematol Oncol"},{"issue":"22","key":"pone.0248649.ref034","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2010-01-251348","article-title":"The inherited diseases of hemoglobin are an emerging global health burden","volume":"115","author":"DJ Weatherall","year":"2010","journal-title":"Blood"},{"issue":"10","key":"pone.0248649.ref035","doi-asserted-by":"crossref","first-page":"a011783","DOI":"10.1101\/cshperspect.a011783","article-title":"The natural history of sickle cell disease","volume":"3","author":"GR Serjeant","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"20","key":"pone.0248649.ref036","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia","volume":"332","author":"S Charache","year":"1995","journal-title":"N Engl J Med"},{"issue":"3","key":"pone.0248649.ref037","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030681","article-title":"Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.","volume":"19","author":"R Di Maggio","year":"2018","journal-title":"Int J Mol Sci."},{"issue":"3","key":"pone.0248649.ref038","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jpainsymman.2014.06.007","article-title":"Sickle cell disease patients with and without extremely high hospital use: pain, opioids, and coping.","volume":"49","author":"S-E Brown","year":"2015","journal-title":"J Pain Symptom Manage."},{"issue":"1","key":"pone.0248649.ref039","first-page":"189","article-title":"Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study.","volume":"24","author":"RM Cronin","year":"2019","journal-title":"Hematol Amst Neth"},{"issue":"5","key":"pone.0248649.ref040","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jpain.2016.12.016","article-title":"AAPT Diagnostic Criteria for Chronic Sickle Cell Disease Pain.","volume":"18","author":"C Dampier","year":"2017","journal-title":"J Pain Off J Am Pain Soc"},{"issue":"7","key":"pone.0248649.ref041","doi-asserted-by":"crossref","first-page":"e27027","DOI":"10.1002\/pbc.27027","article-title":"Parent pain catastrophizing predicts child depressive symptoms in youth with sickle cell disease","volume":"65","author":"A Goldstein-Leever","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"pone.0248649.ref042","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/archdischild-2018-314955","article-title":"Patient-reported experience measure in sickle cell disease","volume":"103","author":"S Chakravorty","year":"2018","journal-title":"Arch Dis Child"},{"issue":"1","key":"pone.0248649.ref043","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1590\/0034-7167-2016-0409","article-title":"Quality of life in adults with sickle cell disease: an integrative review of the literature.","volume":"71","author":"SLF de Freitas","year":"2018","journal-title":"Rev Bras Enferm"},{"key":"pone.0248649.ref044","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1477-7525-8-121","article-title":"Double disadvantage: a case control study on health-related quality of life in children with sickle cell disease.","volume":"8","author":"CT Hijmans","year":"2010","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"pone.0248649.ref045","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/A:1012253723272","article-title":"Can parents rate their child\u2019s health-related quality of life? Results of a systematic review.","volume":"10","author":"C Eiser","year":"2001","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"key":"pone.0248649.ref046","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1477-7525-5-2","article-title":"Parent proxy-report of their children\u2019s health-related quality of life: an analysis of 13,878 parents\u2019 reliability and validity across age subgroups using the PedsQL 4.0 Generic Core Scales.","volume":"5","author":"JW Varni","year":"2007","journal-title":"Health Qual Life Outcomes."},{"issue":"1","key":"pone.0248649.ref047","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12955-018-1009-5","article-title":"Quality of life among caregivers of sickle cell disease patients: a cross sectional study.","volume":"16","author":"BM Madani","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"pone.0248649.ref048","unstructured":"ANSM: Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9. Etat des lieux de la consommation des benzodiaz\u00e9pines\u2014Point d\u2019Information [Internet]. 2017 [cited 2021 Feb 01]. Available from: http:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Etat-des-lieux-de-la-consommation-des-benzodiazepines-Point-d-Information."},{"issue":"5","key":"pone.0248649.ref049","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1590\/1516-3180.2015.00171105","article-title":"The relationship between genotype, psychiatric symptoms and quality of life in adult patients with sickle cell disease in S\u00e3o Paulo, Brazil: a cross-sectional study.","volume":"133","author":"\u00c9B Mastandr\u00e9a","year":"2015","journal-title":"Sao Paulo Med J Rev Paul Med."},{"issue":"1","key":"pone.0248649.ref050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15537\/smj.2019.1.22919","article-title":"Systematic psychiatric assessment of patients with sickle cell disease","volume":"40","author":"OS Al Zahrani","year":"2019","journal-title":"Saudi Med J"},{"key":"pone.0248649.ref051","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-244X-14-207","article-title":"Sleep disturbance, depression and pain in adults with sickle cell disease","volume":"14","author":"GR Wallen","year":"2014","journal-title":"BMC Psychiatry"},{"key":"pone.0248649.ref052","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.lfs.2018.08.066","article-title":"Does sickle cell disease have a psychosomatic component? A particular focus on anxiety and depression","volume":"210","author":"ML Toumi","year":"2018","journal-title":"Life Sci"},{"issue":"1","key":"pone.0248649.ref053","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2141.2005.05723.x","article-title":"Cannabis use in sickle cell disease: a questionnaire study","volume":"131","author":"J Howard","year":"2005","journal-title":"Br J Haematol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0248649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T17:42:47Z","timestamp":1616089367000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0248649"}},"subtitle":[],"editor":[{"given":"Ambroise","family":"Wonkam","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":53,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0248649","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]}}}